Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalassaemia intermedia.

J S Wainscoat1, S L Thein, D J Weatherall

  • 1Department of Haematology, John Radcliffe Hospital, Headington, Oxford.

Blood Reviews
|December 1, 1987
PubMed
Summary

Beta thalassaemia intermedia is a milder form of beta thalassaemia major. Genetic factors like specific mutations, alpha thalassaemia, and enhanced gamma-globin expression influence its development, requiring careful patient monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypochromic Anaemias Not Due to Iron Deficiency: Thalassaemia and Sideroblastic Anaemia.

Journal of the Royal College of Physicians of London·2019
Same author

Molecular Medicine.

Bristol medico-chirurgical journal (1963)·2017
Same author

Is medical research in danger of suffering the same fate as the NHS?

QJM : monthly journal of the Association of Physicians·2014
Same author

Commentary on "The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5' HS4" by M. Neishabury et al.

Blood cells, molecules & diseases·2011
Same author

Thalassaemia: the long road from the bedside through the laboratory to the community.

Transfusion medicine (Oxford, England)·2011
Same author

The quiet art revisited.

Lancet (London, England)·2011

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Background:

  • Beta thalassaemia major is a severe genetic blood disorder requiring transfusions.
  • Beta thalassaemia intermedia represents a less severe phenotype in some homozygotes.
  • Understanding the genetic basis of intermedia is crucial for patient management.

Purpose of the Study:

  • To identify genetic factors contributing to beta thalassaemia intermedia.
  • To differentiate intermedia from major forms of beta thalassaemia.
  • To inform clinical follow-up strategies for patients with intermedia.

Main Methods:

  • Genetic analysis of beta thalassaemia patients.
  • Phenotypic correlation with specific genetic mutations.
  • Identification of modifier genes and interactions.

Main Results:

  • Three primary genetic factors identified: mild beta+ mutations, alpha thalassaemia co-inheritance, and enhanced gamma-globin gene expression.
  • Less common interactions, such as compound heterozygosity for beta and delta beta thalassaemia, also lead to intermedia.
  • These genetic factors mitigate the severity seen in beta thalassaemia major.

Conclusions:

  • Beta thalassaemia intermedia arises from specific genetic interactions that reduce the disease's severity.
  • Patients with intermedia require ongoing clinical surveillance for potential complications like hypersplenism and iron overload.
  • Further research into these genetic modifiers can improve therapeutic approaches.

Related Experiment Videos